Discover the latest strategies for biosimilar product development at the Biosimilars Congress India 2017. This highly anticipated event brings together professionals in the pharmaceutical industry to discuss the challenges and opportunities in this lucrative sector. With recent regulatory approvals and revenue generating opportunities, Indian Pharmaceutical companies are increasingly focusing on biosimilars.

Manufacturing biosimilar products is a complex process, with the structure and molecules requiring utmost precision. Even the smallest change in the manufacturing process can have a significant impact on the efficacy and safety of the final drug. Biopharma companies are constantly striving to develop failure-free procedures that comply with stringent regulatory guidelines.

One of the major challenges faced by pharma companies is demonstrating biosimilarity to the reference product. The Biosimilars Congress India 2017, organized by CPhI India, aims to address these challenges and provide a platform for industry professionals to exchange ideas and insights. Don't miss this opportunity to stay updated on the evolving biosimilar pathways and learn from the experts in the field. Join us in Hyderabad for this groundbreaking event.